Randomised, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I Study of QGC001, a Centrally Acting Aminopeptidase A Inhibitor Prodrug

Balavoine, Fabrice ; Azizi, Michel ; Bergerot, Damien ; De Mota, Nadia ; Patouret, Rémi ; Roques, Bernard P. ; Llorens-Cortes, Catherine

Clinical pharmacokinetics, 2014-04, Vol.53 (4), p.385-395 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível